The Implementation of WIPO Standard ST.26 (RECORDING)
You must log in to register
- Non-member - $150
- Member - Free!
Join IPO to hear from the USPTO and WIPO on the implementation of the World Intellectual Property Office (WIPO) Standard ST.26 as the experts discuss the changes to sequence listings filed in patent applications that contain disclosures of nucleotide and/or amino acid sequences. WIPO Standard ST.26, requiring XML formatting, went into effect worldwide on July 1, 2022. The USPTO has adopted new rules to implement this Standard as published at 87 Fed Reg. 30806, (May 20, 2022).
Updates to PCT rules and practice have been implemented to address submission of sequence listings in XML format for PCT applications filed beginning on July 1, 2022. During the webinar, USPTO and WIPO legal and technical experts will present an overview of implementation of WIPO Standard ST.26 at the USPTO for applications filed with USPTO and WIPO for PCT applications.
The presentation will provide guidance on how you will be able to prepare and submit a compliant sequence listing in U.S. patent applications and PCT applications filed on or after July 1, 2022.
PCT Legal Examiner-International Patent Legal Administration
Anish Gupta has been a PCT Legal Examiner within the International Patent Legal Administration at the United States Patent and Trademark Office since 2013. As a Legal Examiner, Anish assists in matters relating to international applications filed under the Patent Cooperation Treaty and national applications filed under 35 U.S.C. 371. Since joining International Patent Legal Administration, he has been a member of the USPTO ST.26 Task Force group and has been involved with the drafting and implementation of Standard ST.26 and its annexes. Anish has also assisted in the development of the Federal Rules that implemented ST.26 for U.S. applications. Prior to the joining International Patent Legal Administration, Anish was a primary patent examiner in the biotechnology group at the USPTO. As a patent Examiner, he examined biotechnology patent applications focusing on peptide/protein subject matter. Anish holds a Juris Doctorate from The American University, Washington College of Law and a B.S. in Chemistry from the University of Pittsburgh.
Assistant General Counsel - Patents
Johnson & Johnson
Wayne Jaeschke is a patent attorney in the Johnson and Johnson Global Legal Organization with close to 30 years of experience providing counsel to clients in the healthcare, pharmaceutical, and medical device fields. Wayne currently serves as co Vice-Chair to IPO’s International Patent Law and Trade Committee and Chair of the WIPO and International Patent Practice sub-committee.
Legal Officer, PCT Legal and User Relations Division
World Intellectual Property Organization
Hanna Kang works as Legal Officer in the PCT Legal and User Relations Division of the World Intellectual Property Organization (WIPO) in Geneva, Switzerland. In her role, Hanna helps draft and implement changes to the PCT legal framework, offers training courses and advises users on PCT procedures. A national of the United States of America, Hanna joined WIPO in 2013 and worked as Associate Legal Officer in the WIPO Arbitration and Mediation Center prior to joining the PCT Legal and User Relations Division. Prior to studying law, Hanna worked in biotechnology. She is a member of the State Bar of California and licensed before the USPTO.
Senior Legal Advisor in the Office of Patent Legal Administration (OPLA)
Mary C. Till is a Senior Legal Advisor in the Office of Patent Legal Administration (OPLA) at the USPTO. She focuses on administration of the Patent Term Restoration provisions of the Hatch-Waxman Act on behalf of the USPTO. Additionally, she is involved with specialty projects including reexamination, reissue and training to the examining corps and the public on relevant case law, such as subject matter eligibility. Most recently, she has been involved with various projects associated with provisions of the America Invents Act. Prior to joining OPLA, she worked in private practice at Foley & Lardner in Washington, DC. In private practice, Ms. Till was actively engaged in procuring patent protection for various life science corporations and several universities, counseling the entities regarding product launches and providing opinions of counsel on freedom to operate, validity, infringement, invalidity and due diligence issues. She also was a patent examiner from 1993 until 1997, when she joined Foley & Lardner. She earned her J.D. from American University’s Washington College of Law, cum laude. She received a B.S. in Chemistry from Gannon University and her M.S. in Organic Chemistry from Virginia Tech. She is admitted to the bar of Virginia and to practice before the United States Patent and Trademark Office.